Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Soleno Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $105.27, which forecasts a 231.87% increase in the stock price over the next year. The lowest target is $75 and the highest is $145.

Price Target: $105.27 (+231.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$75	$105.27	$106	$145
Change	+136.44%	+231.87%	+234.17%	+357.12%

Analyst Ratings

The average analyst rating for Soleno Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	4	4	4	5	5
Buy	5	6	6	6	6	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Leland Gershell Oppenheimer	Oppenheimer	Buy Maintains $110 → $80	Buy	Maintains	$110 → $80	+152.21%	Mar 18, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $120 → $100	Strong Buy	Maintains	$120 → $100	+215.26%	Mar 4, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $114 → $110	Buy	Maintains	$114 → $110	+246.78%	Feb 27, 2026
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Maintains $120 → $85	Strong Buy	Maintains	$120 → $85	+167.97%	Feb 26, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $106 → $114	Buy	Maintains	$106 → $114	+259.39%	Jan 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

477.25M

Increased by 150.65%

from 190.41M

Revenue Next Year

744.97M

Increased by 56.10%

from 477.25M

EPS This Year

4.30

Increased by 1,001.68%

from 0.39

EPS Next Year

6.95

Increased by 61.79%

from 4.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	190.41M	477.25M	744.97M
Revenue Growth	-	-	-	-	-	150.65%	56.10%
EPS	-5.81	-2.87	-2.36	-4.38	0.39	4.30	6.95
EPS Growth	-	-	-	-	-	1,001.68%	61.79%
Forward PE	-	-	-	-	-	7.38	4.56
No. Analysts	-	-	-	-	-	15	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	544.7M	924.0M
Avg	477.3M	745.0M
Low	425.0M	613.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	186.1%	93.6%
Avg	150.6%	56.1%
Low	123.2%	28.5%

EPS Forecast

EPS	2026	2027	2028
High	5.83	10.42
Avg	4.30	6.95
Low	2.85	5.21

EPS Growth

EPS Growth	2026	2027	2028
High	1,394.2%	142.4%
Avg	1,001.7%	61.8%
Low	631.2%	21.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.